Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China.

Zhu Y, Zhu J, Gao X, Sun Y, Yan H, Du W, Wang Y, Li X

Open source

DOI
10.3389/fpubh.2025.1705030
Published
2025
Container
Frontiers in public health
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fpubh.2025.1705030,
  title = {Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China.},
  author = {Zhu Y and Zhu J and Gao X and Sun Y and Yan H and Du W and Wang Y and Li X},
  year = {2025},
  journal = {Frontiers in public health},
  doi = {10.3389/fpubh.2025.1705030},
  url = {https://doi.org/10.3389/fpubh.2025.1705030}
}

RIS

TY  - JOUR
TI  - Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China.
AU  - Zhu Y
AU  - Zhu J
AU  - Gao X
AU  - Sun Y
AU  - Yan H
AU  - Du W
AU  - Wang Y
AU  - Li X
PY  - 2025
JO  - Frontiers in public health
DO  - 10.3389/fpubh.2025.1705030
UR  - https://doi.org/10.3389/fpubh.2025.1705030
ER  - 

APA

Y, Z., J, Z., X, G., Y, S., H, Y., W, D., Y, W., & X, L. (2025). Impact of National Drug Price Negotiation policy on the innovation performance of biopharmaceutical industry in China.. Frontiers in public health. https://doi.org/10.3389/fpubh.2025.1705030

Source records